PMC9354981_01
Case 1: (A) Diagnosis of right SDH; (B) The size of SDH significantly decreased after 9 days of the treatment; (C) SDH continued to decrease in size after 1 month of treatment; (D) the residual hematomas resolved 3 months after the treatment. Case 2: (E) Diagnosis of bilateral SDH; (F) the size of the right SDH significantly decreased after 1 month of the treatment; (G) the residual hematomas resolved 4 months after the treatment. Case 3: (H) Diagnosis of bilateral SDH; (I) Headache considerably decreased after 15 days of treatment but without a reduction in the size of the hematoma on MRI images; (J) Seventeen days later, a head MRI revealed an expansion of the SDH, and the patient underwent surgery after 2 days; (K) Two months later, the patient recovered well without any neurological sequelae. Arrows and dashed lines indicate the locations of SDH. SDH, subdural hematoma; MRI, magnetic resonance imaging.
fneur-13-900145-g0002.jpg
PMC9354981_03_fneur-13-900145-g0002.jpg
F2
An MRI of the head was conducted and showed bilateral SDH (Figure 2H), with slight delirium, but without other marked neurological impairment. ATO. After 15 days of the treatment, although there was no reduction in the hematoma size on MRI images (Figure 2I), his headache considerably decreased, and he was discharged from the hospital with continuous oral administration of Atorvastatin and DEX. Head MRI revealed a slight expansion of the bilateral frontotemporal paroccipital chronic SDH (Figure 2J). Two months later, the patient recovered well without any neurological sequelae (Figure 2K).
PMC9354981_02
Case 1: (A) Diagnosis of right SDH; (B) The size of SDH significantly decreased after 9 days of the treatment; (C) SDH continued to decrease in size after 1 month of treatment; (D) the residual hematomas resolved 3 months after the treatment. Case 2: (E) Diagnosis of bilateral SDH; (F) the size of the right SDH significantly decreased after 1 month of the treatment; (G) the residual hematomas resolved 4 months after the treatment. Case 3: (H) Diagnosis of bilateral SDH; (I) Headache considerably decreased after 15 days of treatment but without a reduction in the size of the hematoma on MRI images; (J) Seventeen days later, a head MRI revealed an expansion of the SDH, and the patient underwent surgery after 2 days; (K) Two months later, the patient recovered well without any neurological sequelae. Arrows and dashed lines indicate the locations of SDH. SDH, subdural hematoma; MRI, magnetic resonance imaging.
fneur-13-900145-g0002.jpg
PMC9354981_03_fneur-13-900145-g0002.jpg
F2
An MRI of the head was conducted and showed bilateral SDH (Figure 2H), with slight delirium, but without other marked neurological impairment. ATO. After 15 days of the treatment, although there was no reduction in the hematoma size on MRI images (Figure 2I), his headache considerably decreased, and he was discharged from the hospital with continuous oral administration of Atorvastatin and DEX. Head MRI revealed a slight expansion of the bilateral frontotemporal paroccipital chronic SDH (Figure 2J). Two months later, the patient recovered well without any neurological sequelae (Figure 2K).
PMC9354981_03
Case 1: (A) Diagnosis of right SDH; (B) The size of SDH significantly decreased after 9 days of the treatment; (C) SDH continued to decrease in size after 1 month of treatment; (D) the residual hematomas resolved 3 months after the treatment. Case 2: (E) Diagnosis of bilateral SDH; (F) the size of the right SDH significantly decreased after 1 month of the treatment; (G) the residual hematomas resolved 4 months after the treatment. Case 3: (H) Diagnosis of bilateral SDH; (I) Headache considerably decreased after 15 days of treatment but without a reduction in the size of the hematoma on MRI images; (J) Seventeen days later, a head MRI revealed an expansion of the SDH, and the patient underwent surgery after 2 days; (K) Two months later, the patient recovered well without any neurological sequelae. Arrows and dashed lines indicate the locations of SDH. SDH, subdural hematoma; MRI, magnetic resonance imaging.
fneur-13-900145-g0002.jpg
PMC9354981_03_fneur-13-900145-g0002.jpg
F2
An MRI of the head was conducted and showed bilateral SDH (Figure 2H), with slight delirium, but without other marked neurological impairment. ATO. After 15 days of the treatment, although there was no reduction in the hematoma size on MRI images (Figure 2I), his headache considerably decreased, and he was discharged from the hospital with continuous oral administration of Atorvastatin and DEX. Head MRI revealed a slight expansion of the bilateral frontotemporal paroccipital chronic SDH (Figure 2J). Two months later, the patient recovered well without any neurological sequelae (Figure 2K).